G protein-coupled receptor signaling in human ductal pancreatic cancer cells: Neurotensin responsiveness and mitogenic stimulation
- 4 December 2000
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 186 (1) , 53-64
- https://doi.org/10.1002/1097-4652(200101)186:1<53::aid-jcp1004>3.0.co;2-q
Abstract
Neuropeptides and their corresponding G protein–coupled receptors (GPCRs) are increasingly implicated in the autocrine/paracrine stimulation of growth of human cancers. We report that neurotensin induced rapid Ca2+ mobilization from intracellular stores followed by Ca2+ influx in five human ductal pancreatic cancer cell lines: HPAF‐II, Capan‐1, Capan‐2, PANC‐1, and MIA PaCa‐2. In addition, most cell lines exhibited Ca2+ responses to multiple neuropeptides including bombesin, bradykinin, cholecystokinin, and vasopressin and to bioactive lipids, including lysophosphatidic acid (LPA), that also act via GPCRs. The well‐differentiated line HPAF‐II responded to at least seven independent GPCR agonists. The concentrations of neurotensin required to induce half‐maximal effects (EC50) in HPAF‐II and PANC‐1 cells were 5 and 8 nM, respectively. Digital fluorescence image analysis to measure Ca2+ responses in single cells revealed that 90% or more of HPAF‐II and PANC‐1 cells responded to 10 nM neurotensin. Addition of neurotensin to PANC‐1 cells also induced rapid and dose‐dependent extracellular‐regulated protein kinase (ERK‐1 and ERK‐2) activation and subsequently, stimulated DNA synthesis. The signaling complexity of GPCRs uncovered by these studies reveals a new aspect in the biology of human pancreatic cancer and could offer the basis for new approaches to the treatment of this disease. J. Cell. Physiol. 186:53–64, 2001.Keywords
This publication has 36 references indexed in Scilit:
- Enhancement of the Migration of Metastatic Human Breast Cancer Cells by Phosphatidic AcidBiochemical and Biophysical Research Communications, 2000
- The Effect of Bombesin, Cholecystokinin, Gastrin, and Their Antagonists on Proliferation of Pancreatic Cancer Cell LinesScandinavian Journal of Gastroenterology, 1999
- Pancreatic cancerCurrent Opinion in Oncology, 1998
- Pro-neurotensin/Neuromedin N Expression and Processing in Human Colon Cancer Cell LinesBiochemical and Biophysical Research Communications, 1998
- Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.Journal of Clinical Investigation, 1997
- Regulation of Phosphoinositide Phospholipases by Hormones, Neurotransmitters, and Other Agonists Linked to G ProteinsAnnual Review of Pharmacology and Toxicology, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancerInternational Journal of Cancer, 1995
- Bombesin Inhibits Growth of Pancreatic Ductal Adenocarcinoma (H2T) in Nude MicePancreas, 1994
- Inhibition by neurotensin of azaserine-induced carcinogenesis in rat pancreasInternational Journal of Cancer, 1991